This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Finch, R. A. Articles by Zhang, N. Search for Related Content PubMed PubMed Citation Articles by Finch, R. A. Articles by Zhang, N.

mdmx Is a Negative Regulator of p53 Activity in Vivo

Lexicon Genetics, Incorporated, The Woodlands, Texas 77381

Regulation of p53 protein activity is required for normal embryogenesis, tumor suppression, and cellular response to DNA damage. Here we report that loss of mdmx, a p53-binding protein, results in midgestational embryo lethality, a phenotype that is completely rescued by the absence of p53. Mice homozygous for both mdmx and p53 null mutations are viable and appear developmentally normal. Fibroblasts derived from embryos with reduced mdmx expression demonstrate a decreased growth rate and increased UV-induced apoptosis compared with wild-type cells and contain elevated levels of p53 and several p53 target proteins including the proapoptotic bax protein. These observations demonstrate that mdmx functions as a critical negative regulator of p53 in vivo.

This article has been cited by other articles:

				J. Kallen, A. Goepfert, A. Blechschmidt, A. Izaac, M. Geiser, G. Tavares, P. Ramage, P. Furet, K. Masuya, and J. Lisztwan Crystal Structures of Human MdmX (HdmX) in Complex with p53 Peptide Analogues Reveal Surprising Conformational Changes J. Biol. Chem., March 27, 2009; 284(13): 8812 - 8821. [Abstract] [Full Text] [PDF]

				J. A. Barboza, T. Iwakuma, T. Terzian, A. K. El-Naggar, and G. Lozano Mdm2 and Mdm4 Loss Regulates Distinct p53 Activities Mol. Cancer Res., June 1, 2008; 6(6): 947 - 954. [Abstract] [Full Text] [PDF]

				V. Lopez-Pajares, M. M. Kim, and Z.-M. Yuan Phosphorylation of MDMX Mediated by Akt Leads to Stabilization and Induces 14-3-3 Binding J. Biol. Chem., May 16, 2008; 283(20): 13707 - 13713. [Abstract] [Full Text] [PDF]

				A. Veerakumarasivam, H. E. Scott, S.-F. Chin, A. Warren, M. J. Wallard, D. Grimmer, K. Ichimura, C. Caldas, V. P. Collins, D. E. Neal, et al. High-Resolution Array-Based Comparative Genomic Hybridization of Bladder Cancers Identifies Mouse Double Minute 4 (MDM4) as an Amplification Target Exclusive of MDM2 and TP53 Clin. Cancer Res., May 1, 2008; 14(9): 2527 - 2534. [Abstract] [Full Text] [PDF]

				D. M. Gilkes, Y. Pan, D. Coppola, T. Yeatman, G. W. Reuther, and J. Chen Regulation of MDMX Expression by Mitogenic Signaling Mol. Cell. Biol., March 15, 2008; 28(6): 1999 - 2010. [Abstract] [Full Text] [PDF]

				Z. Matijasevic, H. A. Steinman, K. Hoover, and S. N. Jones MdmX Promotes Bipolar Mitosis To Suppress Transformation and Tumorigenesis in p53-Deficient Cells and Mice Mol. Cell. Biol., February 15, 2008; 28(4): 1265 - 1273. [Abstract] [Full Text] [PDF]

				F. Bartel, J. Jung, A. Bohnke, E. Gradhand, K. Zeng, C. Thomssen, and S. Hauptmann Both Germ Line and Somatic Genetics of the p53 Pathway Affect Ovarian Cancer Incidence and Survival Clin. Cancer Res., January 1, 2008; 14(1): 89 - 96. [Abstract] [Full Text] [PDF]

				T. Terzian, Y. Wang, C. S. Van Pelt, N. F. Box, E. L. Travis, and G. Lozano Haploinsufficiency of Mdm2 and Mdm4 in Tumorigenesis and Development Mol. Cell. Biol., August 1, 2007; 27(15): 5479 - 5485. [Abstract] [Full Text] [PDF]

				S. Xiong, C. S. Van Pelt, A. C. Elizondo-Fraire, B. Fernandez-Garcia, and G. Lozano Loss of Mdm4 Results in p53-Dependent Dilated Cardiomyopathy Circulation, June 12, 2007; 115(23): 2925 - 2930. [Abstract] [Full Text] [PDF]

				M. Maetens, G. Doumont, S. D. Clercq, S. Francoz, P. Froment, E. Bellefroid, U. Klingmuller, G. Lozano, and J.-C. Marine Distinct roles of Mdm2 and Mdm4 in red cell production Blood, March 15, 2007; 109(6): 2630 - 2633. [Abstract] [Full Text] [PDF]

				J.-C. W. Marine, M. A. Dyer, and A. G. Jochemsen MDMX: from bench to bedside J. Cell Sci., February 1, 2007; 120(3): 371 - 378. [Abstract] [Full Text] [PDF]

				M. Wade, E. T. Wong, M. Tang, J. M. Stommel, and G. M. Wahl Hdmx Modulates the Outcome of P53 Activation in Human Tumor Cells J. Biol. Chem., November 3, 2006; 281(44): 33036 - 33044. [Abstract] [Full Text] [PDF]

				J. T. Patton, L. D. Mayo, A. D. Singhi, A. V. Gudkov, G. R. Stark, and M. W. Jackson Levels of HdmX Expression Dictate the Sensitivity of Normal and Transformed Cells to Nutlin-3. Cancer Res., March 15, 2006; 66(6): 3169 - 3176. [Abstract] [Full Text] [PDF]

				S. Xiong, C. S. Van Pelt, A. C. Elizondo-Fraire, G. Liu, and G. Lozano Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development PNAS, February 28, 2006; 103(9): 3226 - 3231. [Abstract] [Full Text] [PDF]

				J. D. Grier, S. Xiong, A. C. Elizondo-Fraire, J. M. Parant, and G. Lozano Tissue-Specific Differences of p53 Inhibition by Mdm2 and Mdm4 Mol. Cell. Biol., January 1, 2006; 26(1): 192 - 198. [Abstract] [Full Text] [PDF]

				K. Okamoto, K. Kashima, Y. Pereg, M. Ishida, S. Yamazaki, A. Nota, A. Teunisse, D. Migliorini, I. Kitabayashi, J.-C. Marine, et al. DNA Damage-Induced Phosphorylation of MdmX at Serine 367 Activates p53 by Targeting MdmX for Mdm2-Dependent Degradation Mol. Cell. Biol., November 1, 2005; 25(21): 9608 - 9620. [Abstract] [Full Text] [PDF]

				L. Chen, C. Li, Y. Pan, and J. Chen Regulation of p53-MDMX Interaction by Casein Kinase 1 Alpha Mol. Cell. Biol., August 1, 2005; 25(15): 6509 - 6520. [Abstract] [Full Text] [PDF]

				M. K. Saville, A. Sparks, D. P. Xirodimas, J. Wardrop, L. F. Stevenson, J.-C. Bourdon, Y. L. Woods, and D. P. Lane Regulation of p53 by the Ubiquitin-conjugating Enzymes UbcH5B/C in Vivo J. Biol. Chem., October 1, 2004; 279(40): 42169 - 42181. [Abstract] [Full Text] [PDF]

				D. Danovi, E. Meulmeester, D. Pasini, D. Migliorini, M. Capra, R. Frenk, P. de Graaf, S. Francoz, P. Gasparini, A. Gobbi, et al. Amplification of Mdmx (or Mdm4) Directly Contributes to Tumor Formation by Inhibiting p53 Tumor Suppressor Activity Mol. Cell. Biol., July 1, 2004; 24(13): 5835 - 5843. [Abstract] [Full Text] [PDF]

				T. Hosaka, W. H. Biggs III, D. Tieu, A. D. Boyer, N. M. Varki, W. K. Cavenee, and K. C. Arden Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification PNAS, March 2, 2004; 101(9): 2975 - 2980. [Abstract] [Full Text] [PDF]

				F. Mancini, F. Gentiletti, M. D'Angelo, S. Giglio, S. Nanni, C. D'Angelo, A. Farsetti, G. Citro, A. Sacchi, A. Pontecorvi, et al. MDM4 (MDMX) Overexpression Enhances Stabilization of Stress-induced p53 and Promotes Apoptosis J. Biol. Chem., February 27, 2004; 279(9): 8169 - 8180. [Abstract] [Full Text] [PDF]

				A. Chavez-Reyes, J. M. Parant, L. L. Amelse, R. M. de Oca Luna, S. J. Korsmeyer, and G. Lozano Switching Mechanisms of Cell Death in mdm2- and mdm4-null Mice by Deletion of p53 Downstream Targets Cancer Res., December 15, 2003; 63(24): 8664 - 8669. [Abstract] [Full Text] [PDF]

				T. Iwakuma and G. Lozano MDM2, An Introduction Mol. Cancer Res., December 1, 2003; 1(14): 993 - 1000. [Abstract] [Full Text] [PDF]

				U. M. Moll and O. Petrenko The MDM2-p53 Interaction Mol. Cancer Res., December 1, 2003; 1(14): 1001 - 1008. [Abstract] [Full Text] [PDF]

				G. Ganguli and B. Wasylyk p53-Independent Functions of MDM2 Mol. Cancer Res., December 1, 2003; 1(14): 1027 - 1035. [Abstract] [Full Text] [PDF]

				H. Kawai, D. Wiederschain, H. Kitao, J. Stuart, K. K. C. Tsai, and Z.-M. Yuan DNA Damage-induced MDMX Degradation Is Mediated by MDM2 J. Biol. Chem., November 14, 2003; 278(46): 45946 - 45953. [Abstract] [Full Text] [PDF]

				Y. Pan and J. Chen MDM2 Promotes Ubiquitination and Degradation of MDMX Mol. Cell. Biol., August 1, 2003; 23(15): 5113 - 5121. [Abstract] [Full Text] [PDF]

				E. Meulmeester, R. Frenk, R. Stad, P. de Graaf, J.-C. Marine, K. H. Vousden, and A. G. Jochemsen Critical Role for a Central Part of Mdm2 in the Ubiquitylation of p53 Mol. Cell. Biol., July 15, 2003; 23(14): 4929 - 4938. [Abstract] [Full Text] [PDF]

				H. Kawai, D. Wiederschain, and Z.-M. Yuan Critical Contribution of the MDM2 Acidic Domain to p53 Ubiquitination Mol. Cell. Biol., July 15, 2003; 23(14): 4939 - 4947. [Abstract] [Full Text] [PDF]

				Y. YANG and X. YU Regulation of apoptosis: the ubiquitous way FASEB J, May 1, 2003; 17(8): 790 - 799. [Abstract] [Full Text] [PDF]

				S. X. Zeng, Y. Jin, D. T. Kuninger, P. Rotwein, and H. Lu The Acetylase Activity of p300 Is Dispensable for MDM2 Stabilization J. Biol. Chem., February 21, 2003; 278(9): 7453 - 7458. [Abstract] [Full Text] [PDF]

				P. Wang, H. Gao, Y. Ni, B. Wang, Y. Wu, L. Ji, L. Qin, L. Ma, and G. Pei beta -Arrestin 2 Functions as a G-Protein-coupled Receptor-activated Regulator of Oncoprotein Mdm2 J. Biol. Chem., February 14, 2003; 278(8): 6363 - 6370. [Abstract] [Full Text] [PDF]

				J. C. Badciong and A. L. Haas MdmX Is a RING Finger Ubiquitin Ligase Capable of Synergistically Enhancing Mdm2 Ubiquitination J. Biol. Chem., December 13, 2002; 277(51): 49668 - 49675. [Abstract] [Full Text] [PDF]

				C. Li, L. Chen, and J. Chen DNA Damage Induces MDMX Nuclear Translocation by p53-Dependent and -Independent Mechanisms Mol. Cell. Biol., November 1, 2002; 22(21): 7562 - 7571. [Abstract] [Full Text] [PDF]